Uloric and Appetite disorder - a phase IV clinical study of FDA data

Summary:

Appetite disorder is reported as a side effect among people who take Uloric (febuxostat), especially for people who are male, 60+ old, also take Omnaris, and have Ulcerative colitis.

The phase IV clinical study analyzes which people have Appetite disorder when taking Uloric. It is created by eHealthMe based on reports of 7,878 people who have side effects when taking Uloric from the FDA, and is updated regularly.

What is Uloric?

Uloric has active ingredients of febuxostat. It is often used in gout. eHealthMe is studying from 8,067 Uloric users. Check the latest studies of Uloric.

What is Appetite disorder?

Appetite disorder (abnormal eating habits) is found to be associated with 715 drugs and 706 conditions by eHealthMe. Check the latest studies of Appetite disorder.

On Jul, 11, 2026

7,878 people reported to have side effects when taking Uloric.
Among them, 20 people (0.25%) have Appetite disorder.

Among these 20 people:

What is the gender of people who have Appetite disorder when taking Uloric? *

female: 10.53 %
male: 89.47 %

What is the age of people who have Appetite disorder when taking Uloric? *

What are other drugs people take besides Uloric? *

What are other side effects people have besides Appetite disorder? *

Diarrhea: 17 people, 85.00%
Tonsil Cancer: 17 people, 85.00%
Nausea (feeling of having an urge to vomit): 2 people, 10.00%
Weight Decreased: 1 person, 5.00%
Gastric Ph Decreased: 1 person, 5.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.00%
Blood Magnesium Abnormal: 1 person, 5.00%
Cardiac Disorder: 1 person, 5.00%
Chest Pain: 1 person, 5.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.00%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 17 people, 85.00%
High Blood Cholesterol: 2 people, 10.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.00%
Pain: 2 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
High Blood Pressure: 2 people, 10.00%
Vitamin B Complex Deficiency: 1 person, 5.00%
Asthma: 1 person, 5.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.00%
Blood Uric Acid Abnormal: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Uloric and have Appetite disorder?

- Check whether Appetite disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Uloric:

Uloric (8,067 reports)

Browse all side effects of Uloric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite disorder:

Appetite disorder (715 drugs)

Browse all the conditions that are associated with Appetite disorder:

Appetite disorder (706 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on febuxostat (the active ingredients of Uloric) and Uloric (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.